Objective: To assess whether type of milk supplementation provided to breastfeeding late preterm infants was associated with hospital length of stay (LOS) or breastfeeding status at discharge.
L ate preterm infants (LPIs) born between 34 and 36 6/7 weeks gestational age are at increased risk of morbidity and mortality (Academy of Breastfeeding Medicine [ABM], 2016) . Approximately 9.6% of U.S. births are preterm (<37 weeks), and approximately 72% of those births are defined as late preterm. This figure represents almost 275,000 of the nearly 4 million annual births in the United States (Martin, Hamilton, Osterman, Driscoll, & Matthews, 2017) . Much of the increased morbidity and mortality in LPIs is related to feeding difficulties. Effective oral feeding behavior is dependent on the physical maturity of the infant's brain. Because one third of a neonate's brain develops between 35 and 41 weeks gestation (Hallowell & Spatz, 2012) , many LPIs are born with immature neurological systems, which results in inconsistent sleep/wake cycles and observable feeding cues and fatigue while feeding at the breast (Briere, Lucas, McGrath, Lussier, & Brownell, 2015; Cartwright, Atz, Newman, Mueller, & Demirci, 2017) . Late preterm infants may also be similar in birth weight to healthy, term infants, which leads families and health care providers to assume that they can be treated in the same way as term newborns. In reality, LPIs are at increased risk of respiratory distress, poor thermoregulation, decreased stamina and alertness, and weaker sucking and ineffective milk transfer at the breast, all of which can increase the risk of hypoglycemia, hyperbilirubinemia, weight loss, delay of discharge, hospital readmission after discharge, and breastfeeding failure (Adamkin, 2006; Boyle et al., 2015) .
Whereas breastfeeding, or human milk feeding, is recommended for all infants (excluding contraindications) for the first 1 to 2 years of life, it is even more important for optimal growth and brain development in preterm infants (American Academy of Pediatrics [AAP], 2012; Briere et al., 2015) . Exclusively breastfed infants have increased white matter development in several brain regions that affects cognitive and behavioral outcomes (Deoni et al., 2013) . One theory is that human milk is responsible for the difference in brain development, particularly the long-chain polyunsaturated fatty acids that infants accrue rapidly in their brains during the last trimester of pregnancy (Hallowell & Spatz, 2012) . Because preterm infants are born before brain growth is complete, they are even more reliant on the human milk fatty acids in their diets. In addition, preterm infants who are not fed human milk diets are at significantly increased risk of necrotizing enterocolitis, sepsis, gastrointestinal and respiratory infections, sudden infant death syndrome, and a greater number of hospital readmissions in the first year of life (AAP, 2012) .
Optimal care to promote breastfeeding during the birth hospitalization includes skin-to-skin contact, early initiation of breastfeeding, rooming-in or nonseparation of mother and newborn, limiting formula supplementation, and provision of skilled lactation support (Munn, Newman, Mueller, Phillips, & Taylor, 2016; World Health Organization, 1991) . These practices are even more important for mothers of LPIs who may have delayed lactogenesis or experience challenges with initiation of breastfeeding (Meier, Furman, & Degenhardt, 2007) . Because LPIs are at increased risk of poor breastfeeding, they are even more likely to receive formula supplementation and to have shorter duration of breastfeeding (Nyqvist et al., 2013) . Although optimal breastfeeding practices are helpful, LPIs also require closer monitoring of feedings to ensure adequate intake, and mothers need skilled support to protect their milk supplies for long-term breastfeeding (Sables-Baus et al., 2013) .
Mothers of LPIs often need to initiate milk expression in the hospital for supplemental feedings until their infants mature enough (38-40 weeks gestational age) to effectively breastfeed consistently (Briere et al., 2015) . Some hospitals have policies to define medical indications for supplementation of breastfed infants, particularly for newborns on a mother-baby unit, starting first with mother's own expressed milk and then the use of formula (Mattsson, Funkquist, Wickstrom, Nyqvist, & Volgsten, 2015) . Many medical organizations and protocols recommend supplementation with expressed mother's own milk as available and then pasteurized donor human milk (PDHM) to improve outcomes and avoid formula supplementation (AAP, 2012; ABM, 2016 ; Association of Women's Health, Obstetric and Neonatal Nurses, 2014) . Use of PDHM is the standard of care in most U.S. NICUs for very-low-birth-weight infants, yet PDHM is not routinely recognized as an option for medically indicated supplementation of term or late preterm infants (Briere et al., 2015) . Briere et al. (2015) described actual hospital policies that may exclude LPIs from receipt of PDHM. Several researchers who studied LPIs and breastfeeding outcomes reported the use of formula for supplementation as the only option after expressed mother's milk (Gianni et al., 2016; Goyal, Attanasio, & Kozhimannil, 2014; Mattsson et al., 2015) . Many clinical protocols or guidelines for breastfeeding LPIs contain recommendations for the use of PDHM when supplementation is medically indicated, but no published research is referenced to support this recommendation (AAP, 2012; ABM, 2014 ABM, , 2016 Meier, Patel, Wright, & Engstrom, 2013) . In their overview of policy statements and practice guidelines related to breastfeeding LPIs, Briere et al. (2015) concluded that more research was needed to establish the use and benefits of donor milk for supplementation when a mother's own milk was not available. Last, the U.S. Surgeon General called for development of evidencebased clinical guidelines for the use of banked donor milk, particularly in infants with low or very low birth weight or prematurity (U.S. Department of Health and Human Services, 2011) . To address these research gaps, we examined the type of milk provided to LPIs admitted to a mother-baby unit, including supplementation with PDHM, expressed human milk, and formula. The primary aim of our study was to evaluate whether length of stay (LOS) in the hospital differed by the type of supplemental milk provided. We also examined associations with breastfeeding status Late preterm infants need human milk for optimal growth and brain development but are at increased risk of poor breastfeeding and shorter breastfeeding duration.
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at hospital discharge as a secondary outcome of interest.
Methods

Setting and Sample
We conducted a retrospective chart review of LPIs at 35 0/7 to 36 6/7 weeks gestational age who were admitted to the mother-baby unit of a tertiary care teaching hospital in Oklahoma during a 2-year period, November 1, 2014, through October 31, 2016. This review did not include LPIs born in the 34th week of gestation because of the facility's policy to directly admit all preterm infants younger than 35 weeks gestational age to the NICU. The hospital is formally working toward Baby-Friendly Hospital designation; therefore, standard care practices to support breastfeeding couplets included rooming-in, immediate skin-to-skin contact, and assistance with initiation of breastfeeding within the first hour after birth. The hospital also had policies that defined supplementation of breastfeeding infants when medically necessary that included the use of PDHM when a mother's own milk was not available in the NICU or the mother-baby unit. The study period was selected to include the two most recent calendar years of births after the establishment of the state's nonprofit milk bank in late 2013.
To maintain data integrity, the chart review was limited to births that occurred before the hospital changed to a new documentation system in November 2016. A total of 624 late preterm births were identified from an electronic search of maternal hospital admissions during the study period. Infants directly admitted to the NICU were excluded (n ¼ 226). The documentation system for each infant admitted to the mother-baby unit was then manually reviewed to confirm eligibility. Three reviewers were trained to search the mother's and infant's electronic records for requested data using an online, secure data collection tool to ensure reliability. On review of the newborn clinical assessment for gestational age, 155 newborn infants were excluded for gestational age at birth outside the 35 0/7 to 36 6/ 7 week criterion. Additional exclusions included transfer to the NICU (n ¼ 25), infant death caused by anencephaly (n ¼ 1), multiple gestation (n ¼ 26), maternal complications or illness that led to separation (n ¼ 5), and infants who entered into state custody (n ¼ 3). The final sample size for analysis included 183 LPIs.
For power calculations, we assumed a baseline mean length of hospital stay of 2.5 days for LPIs admitted to the mother-baby unit (Aly, Hoffman, ElDib, Said, & Mohamed, 2015; Harron, Gilbert, Cromwell, Oddie, & van der Meulen, 2017; Mattsson et al., 2015) , with 70% initiating breastfeeding (Radtke, 2011) and 20% of those feeding exclusively at the breast without supplementation (Zanardo et al., 2011) . We estimated that a sample size of 180 would have 80% power to detect an incidence rate ratio of 1.55 for the comparison of time to hospital discharge for LPIs who breastfed with supplementation compared with those who breastfed without supplementation, assuming an alpha value of .05 and correlation of .2 between breastfeeding supplementation and other covariates. This study was reviewed and approved by the study site's institutional review board.
Measures
Infant feeding status (breastfeeding, formula feeding) was recorded from the infant's medical record as determined by maternal intent on admission. Among breastfeeding LPIs, supplemental feedings were recorded as expressed human milk, PDHM, or formula, and reason for supplementation was recorded as maternal request, physician order for medical indication, or other. For analysis, milk type was coded and examined as six mutually exclusive categories: breastfeeding only (n ¼ 27, 14.8%), breastfeeding with PDHM supplementation only (n ¼ 8, 4.4%), breastfeeding with expressed human milk supplementation with or without PDHM (n ¼ 12, 6.6%), breastfeeding with supplementation of formula and human milk (expressed human milk or PDHM; n ¼ 14, 7.7%), breastfeeding with formula supplementation only (n ¼ 79, 43.2%), and formula feeding only (n ¼ 43, 23.5%). Because of limited sample size for some categories, milk type categories were collapsed into four categories: breastfeeding only, breastfeeding supplemented with human milk only (expressed human milk or PDHM), breastfeeding with any formula supplementation, and formula feeding only.
The primary outcome of interest, LOS, was calculated by subtracting the date of birth from the date of discharge and was measured in days. Thus, the date of birth was defined as Day 0. Feeding status at the time of hospital discharge was classified in the medical record as three categories designating exclusive breastfeeding, supplemented breastfeeding, or formula feeding.
Among infants who received supplementation, this secondary outcome of interest was defined as a binary indicator of any breastfeeding at the time of hospital discharge. Maternal demographic and medical characteristics collected from the medical record included maternal age, race/ethnicity, parity, insurance status, mode of birth with or without labor induction, and maternal complications such as hypertension and gestational diabetes. Infant characteristics included gestational age at birth, birth weight, sex, and medical complications noted as hypoglycemia, hyperbilirubinemia, and difficulty breastfeeding.
Statistical Analysis
Infant and maternal characteristics were compared by milk type through the use of chisquare tests and Fisher's exact tests. Associations between milk type and LOS were evaluated by means of generalized Poisson regression models with robust standard errors (Harris, Yang, & Hardin, 2012) . Generalized Poisson models are appropriate for count data with underdispersion (i.e., variance smaller than the mean), a violation of the Poisson distribution that can lead to overestimated standard errors (Harris et al., 2012 
Results
The maternal and infant characteristics of the study populations are displayed in Table 1 . The LPIs were born to mothers who were predominantly younger than 35 years of age (85.8%, n ¼ 157), had previous live births (63.9%, n ¼ 117), were obese (60.5%, n ¼ 107), and whose medical coverage was provided by Medicaid (68.3%, n ¼ 125). Most infants were born in the 36th week of gestation (75.4%, n ¼ 138). Hyperbilirubinemia (35.5%, n ¼ 65) and hypoglycemia (28.4%, n ¼ 52) were frequent neonatal complications.
At birth, most mothers initiated breastfeeding (76.5%, n ¼ 140). The majority of breastfed LPIs (113 of 140, 80.7%) received supplementation with human milk or formula during their hospital stays. Among all LPIs, the distribution of milk type was 14.8% (n ¼ 27) exclusive breastfeeding, 10.9% (n ¼ 20) breastfeeding with human milk supplementation, 50.8% (n ¼ 93) breastfeeding with formula supplementation, and 23.5% (n ¼ 43) exclusive formula feeding (see Table 2 ). Of the 113 breastfed LPIs who received supplementation, 69.9% (n ¼ 79) had formula, 12.4% (n ¼ 14) had formula and human milk (expressed human milk or PDHM), 
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I N F O C U S 10.6% (n ¼ 12) had expressed human milk (with or without PDHM), and 7.1% (n ¼ 8) had PDHM only. The mean LOS was 2.91 days (standard deviation ¼ 0.92, range ¼ 1-6 days, median ¼ 3 days; see Figure 1 ). At hospital discharge, 25.7% (n ¼ 47) of LPIs were exclusively breastfeeding, 44.3% (n ¼ 81) were breastfeeding with supplementation, and 30.1% (n ¼ 55) were exclusively formula feeding (see Table 1 ).
Our data indicate that the most frequent reason given for supplementation was maternal request, which occurred for 25.7% (n ¼ 47) of all LPIs. Supplementation by physician order was recorded in 19.1% (n ¼ 35), and 16.9% (n ¼ 31) were supplemented for undetermined reasons. Of the 93 breastfeeding LPIs supplemented with formula, a greater proportion were supplemented because of the mother's request (48%, n ¼ 45), followed by unknown reasons (29%, n ¼ 27) and physician order (23%, n ¼ 21). Supplementation with human milk (expressed human milk or PDHM, n ¼ 20) was due to physician order (70%, n ¼ 14), followed by unknown reasons (20%, n ¼ 4) and maternal request (10%, n ¼ 2).
In unadjusted analyses, LOS was significantly longer for exclusively formula-fed infants (IRR ¼ Table 2 ). After controlling for maternal age, race, medical insurance, parity, cesarean, gestational age, maternal hypertension, physician orders for supplementation, and hyperbilirubinemia, the LOS for breastfed LPIs supplemented with expressed human milk or PDHM was no longer significantly different from exclusively breastfed LPIs, and the rate ratio was attenuated (IRR ¼ 1.14, 95% CI [0.96, 1.37]). When the human milk supplementation group was further separated into those who were supplemented with PDHM only (n ¼ 8, 4.4% overall) and those who were supplemented with the mother's own expressed human milk (with or without the addition of PDHM, n ¼ 12, 6.6% overall), the adjusted association with PDHM supplementation was further reduced (IRR ¼ 1.08, 95% CI [0.88, 1.33], p ¼ .45). Length of stay was similar for late preterm infants exclusively breastfed or human milk-supplemented but increased by 23% among exclusively formula-fed infants.
Furthermore, the magnitude of association with expressed human milk supplementation remained similar to results for the combined group and was not statistically significant (IRR ¼ 1.18, 95% CI [0.95, 1.47], p ¼ .14).
The results for these refined milk supplementation categories, however, should be interpreted with caution because of the small numbers within the separate groups. The association between LOS and use of any formula supplementation whether or not accompanied by human milk supplementation was modest and marginally significant (IRR ¼ 1.11, 95% CI [1.00, 1.23]; see Table 2 ). The results were similar when the formula supplementation group was examined separately for those with formula and human milk supplementation (IRR ¼ Table 2 ). The CIs for mean LOS for these two groups do not overlap, which shows the statistical significance of the observed difference.
Analyses were restricted to the 113 breastfed LPIs who received some form of supplementation to compare the proportion of these infants with "any breastfeeding" at hospital discharge. "Any breastfeeding at discharge" was defined as exclusive breastfeeding or some breastfeeding. All breastfed LPIs who received human milk supplementation without formula supplementation remained classified as exclusively breastfed at hospital discharge (AAP, 2012), whereas 16% (n ¼ 15) of breastfed LPIs who received any formula supplementation with or without the addition of human milk supplementation transitioned to solely formula feeding on the day of hospital discharge (see Table 1 ). Thus, breastfed LPIs who received any formula supplementation were less likely, specifically 0.84 times as likely, to be breastfeeding on the day of discharge compared with breastfed LPIs who received human milk supplementation (risk ratio ¼ .84, 95% CI [0.77, 0.92]; see Table 3 ).
Discussion
Although researchers established a link between human milk supplementation and improved outcomes among very preterm and low-birth-weight infants in the NICU (Abrams, Schanler, Lee, & Rechtman, 2014; Corpeleijn et al., 2016;  The implementation of hospital practices that support human milk supplementation in late preterm infants may deter transition to formula feeding before hospital discharge without increasing hospital stay.
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I N F O C U S Quigley & McGuire, 2014; Sullivan et al., 2010) , the effects of milk supplementation in LPIs have not been adequately assessed. The results of our study indicate similar LOS for breastfed LPIs supplemented with expressed human milk and/ or PDHM when compared with exclusively breastfed LPIs who received no supplement. Exclusively formula-fed LPIs, however, had a statistically significant longer LOS of 3.2 days compared with 2.6 days for exclusively breastfed LPIs. Given the high percentage of LPIs supplemented solely with formula when expressed human milk and/or PDHM were available options, these findings indicate that an opportunity may exist to reduce LOS in LPIs by increasing exclusive breastfeeding rates at discharge. These findings are generally consistent with those of Mattsson et al. (2015) , who evaluated the effects of milk supplementation on LOS among LPIs. In their study of 77 healthy LPIs (34 5/7 to 36 6/7 weeks gestational age) born in a Swedish hospital and cared for in family rooms, they reported a greater mean LOS in LPIs who received formula supplementation on a regular basis than those who were exclusively breastfed. In our study, formula supplementation was also associated with a modestly increased LOS compared with exclusive breastfeeding, but this finding only approached statistical significance, with a p value of .06. Mattsson et al. (2015) evaluated LOS as the unadjusted difference of means and thus did not take potentially confounding factors into account or apply statistical methods considered applicable for count data. Furthermore, donor human milk and expressed human milk were not evaluated because of a hospital policy to reserve the limited supply of PDHM for use only in the NICU. Thus, with this study, we expand on the findings of Mattsson et al. (2015) by addressing methodologic limitations to control for suspected confounders with the use of a multivariable regression technique for count data. Our findings mitigate concerns that the use of PDHM may discourage mothers from breastfeeding (Bertino et al., 2013) . Further research is needed to confirm the absence of an adverse effect of PDHM supplementation on hospital LOS for LPIs and its potential effect on other neonatal outcomes as well as breastfeeding duration after hospital discharge.
The results of this retrospective chart review highlight the challenges in breastfeeding LPIs because more than 80% of breastfeeding LPIs admitted to the mother-baby unit and rooming-in with their mothers received some form of supplementation. Despite the use of PDHM in this facility since 2011 and the supply of PDHM from the state's own nonprofit accredited milk bank since 2013, fewer than one of five (17.7%) breastfeeding LPIs who were provided supplementation in this study received PDHM as a supplement (with or without other types of milk). Most breastfeeding LPIs who received supplementation were supplemented with formula alone or in combination with human milk. These findings are consistent with those from a 2015 Centers for Disease Control and Prevention survey in which only 26% of the responding U.S. hospitals reported that they limited non-breast milk feeding of breastfed infants (Perrine et al., 2015) . This pattern of practice in our study is of particular concern because the hospital has a policy in which the availability of PDHM for medically indicated supplementation on the mother-baby unit is clearly established, that is, its use is not restricted to only those infants admitted to the NICU. Although we do not know why mothers asked for their infants to be supplemented or whether the type of supplementation received corresponded with the type requested, the mothers' requests to supplement could stem from Mannel, R., and Peck, J. D.
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a lack of intention to exclusively breastfeed or a failure of the hospital staff to provide adequate breastfeeding education that included safety and efficacy of PDHM.
Limitations
Several limitations of this study were identified. Because of the small number of LPIs supplemented with human milk, the precision of our estimates and statistical power for the detection of differences between groups was limited, particularly when we further subdivided the group to analyze PDHM and expressed human milk separately. In addition, the eligible study population was initially identified through gestational age recorded at maternal admission. Subsequent manual review of the selected records confirmed the late preterm birth status of the study population that used the gestational age determination after birth. As a retrospective chart review, the study was limited to data recorded for clinical rather than research purposes, which may have affected the quality and detail of some measures. In addition, data on infant feeding were extracted from nursing documentation, and the reason for supplementation was not always clearly stated. This was addressed by analysis of "unknown reason" as a separate category. As a result, the proportion of supplementation attributed to maternal request and physician orders is likely underestimated. Furthermore, data for the covariate of smoking are likely to be incompletely recorded in the medical record. The low prevalence of maternal smoking in our study population suggests that this measure was susceptible to measurement error that may have influenced our ability to adequately assess potential confounding by smoking. Other covariates of potential interest such as any prior preterm live birth or previous breastfeeding experience were not available for evaluation.
The results of this study are generalizable to predominantly low-income, multiparous women with high prevalence of obesity in similar tertiary care hospitals. Similar research should be conducted for infants representative of other LPI populations, including those born to primiparous, nonobese women and in households with moderate socioeconomic status. Most of the mothers had a predisposing risk for not breastfeeding because they were obese and low-income (Dieterich, Felice, O'Sullivan, & Rasmussen, 2013; Kair & Colaizy, 2016 ), yet 76% initiated breastfeeding. This result may reflect the study hospital's pursuit of Baby-Friendly Hospital designation and the implementation of many practices that provide evidence-based support for breastfeeding couplets.
Implications for Practice and Research
Supplementation with formula during the hospital stay is a known risk factor for early cessation of breastfeeding in term infants (Perrine, Scanlon, Ruowei, Odom, & Grummer-Strawn, 2012) , and our study showed similar results with LPIs. Given the known importance of breastfeeding in this vulnerable population (AAP, 2012), our findings reinforced the evidence base that includes supplementation with expressed human milk or PDHM when medical indications exist. Maternal education on the importance of exclusive breastfeeding for LPIs (Kair & Colaizy, 2016) and the potential value of supplementation with PDHM in addition to a mother's expressed milk may also reduce the high percentage of maternal requests for formula supplementation.
Optimal care for LPIs must also include close monitoring of feedings and maternal education to discern when supplementation is truly medically indicated. Nurses can promote breastfeeding through education on LPI behavior, feeding ability, and normal volume of intake. In particular, education for mothers about supplementation options when medically indicated and the importance of human milk supplementation to support LPI brain development and continued breastfeeding could empower more mothers to sustain exclusive breastfeeding. Nurses and physicians have an opportunity to educate themselves and the families they care for about the importance of exclusive breastfeeding for this vulnerable infant population, including the safety and potential efficacy of PDHM.
Conclusion
The high prevalence of supplementation among breastfeeding LPIs underscores the effect of type of milk supplementation on outcomes in this highrisk population. Our findings indicate that human milk supplementation (expressed human milk and/or PDHM) discourages transition to formula feeding before hospital discharge without an associated increase in the LOS. Future studies are needed to examine how organizational and clinical practice patterns positively or negatively affect human milk supplementation patterns among LPIs and to evaluate the continuum of neonatal and breastfeeding outcomes associated with PDHM supplementation as compared with expressed human milk and formula supplementation.
